Zacks Investment Research on MSN

TEVA signs deal with RPRX to accelerate development of vitiligo drug

Teva Pharmaceuticals TEVA announced a funding agreement with Royalty Pharma plc RPRX, under which the latter will provide up ...
Business Insider

Athira Pharma Announces Exclusive License to Lasofoxifene Phase 3 Development Program for Metastatic Breast Cancer Candidate and a Financing for up to $236 Million

Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as Treatment Option for Patients with ESR1-Mutations Financing ...
Newsfirst.lk

75 Additional Rural Roads Slated for Development Under Second Phase of RDA Project

The Road Development Authority (RDA) announced plans to develop 75 additional roads under the second phase of the Rural Road ...
Philippine News Agency

Six-month program aims to improve nutrition for 52 kids

The city’s Health Services Office (HSO) has identified 52 children aged zero to five with nutritional challenges as the initial recipients of its "Nourish to Flourish" program, which supports children ...